Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria

Precise evaluation of the efficacy of immunotherapy is critical in the effective management and treatment of advanced hepatocellular carcinoma (HCC). Therefore, the purpose of this study was to compare the response assessments achieved by different criteria and to evaluate the correlation between su...

Full description

Bibliographic Details

Published in:	Frontiers in oncology Vol. 11; p. 764189
Main Authors:	Zhou, Meng, Zhang, Chunhui, Nie, Jianhua, Sun, Yajuan, Xu, Ye, Wu, Fangfang, Huang, Yuhong, Li, Shun, Wang, Yuan, Zhou, Yang, Zheng, Tongsen
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 09.12.2021
Subjects:	advanced hepatocellular carcinoma immune-related criteria immunotherapy Oncology PD-1 inhibitor traditional evaluation criteria advanced hepatocellular carcinoma immune-related criteria traditional evaluation criteria PD-1 inhibitor immunotherapy
ISSN:	2234-943X, 2234-943X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!